Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amsety is a healthcare company dedicated to improving the lives of individuals with liver conditions through specialized nutrition and digital health solutions. The company developed the first nutrition bar specifically designed for the dietary requirements of liver patients, formulated to be low in sodium and free of refined sugars. Beyond nutritional products, Amsety provides a digital platform that includes the 'Liver Health Score,' a tool for patients to monitor and manage their liver wellness. Their approach combines evidence-based nutrition with patient support tools to address the needs of those with Non-Alcoholic Fatty Liver Disease (NAFLD) and other chronic liver ailments. Amsety collaborates with leading hepatologists and organizations like the American Liver Foundation to promote liver health awareness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amsety.